AI ROSSO faccia con codice binario

Pioneering the Future of Healthcare: Mimesis S.r.l. and the Universal Impact of Regulatory Support

Advancing Towards Regulatory Recognition: Mimesis S.r.l.’s Groundbreaking Effort In a world-first, Mimesis S.r.l., within the innovative In Silico World (ISW) Consortium (https://www.insilico.world), has secured preliminary regulatory acceptance from the European Medicine Agency (EMA) for its UISS-TB-DR simulation platform. This groundbreaking achievement not only marks a historic moment for tuberculosis (TB) vaccine development but also opens the door for a myriad of UISS engine-powered solutions to benefit from regulatory support. The EMA Letter of Support is publicly available following this link. Understanding the Milestone and Its Implications Preliminary Regulatory Support: The EMA’s initial support for the UISS-TB-DR platform acknowledges the innovative approach of Mimesis S.r.l. using the UISS engine. While this marks an important step forward, it comes with the responsibility to address specific limitations and gather additional data to fully meet regulatory standards. Encouraging Innovation with Caution: This phase of regulatory process underscores the importance of continued development and validation. Mimesis S.r.l. is encouraged to navigate these challenges with the aim of achieving full regulatory approval, reflecting a balanced approach to innovation and safety. Navigating the Path to Full Regulatory Approval The journey toward full regulatory approval is marked by this initial acknowledgment from the EMA, which recognizes the innovative potential of the UISS-TB-DR platform. As Mimesis S.r.l. works to address the outlined limitations and expand its research, this moment serves as a stepping stone for broader applications of the UISS engine in healthcare. The commitment to overcoming these challenges reflects a dedication to advancing medical science responsibly. A Collaborative Effort for Healthcare Innovation: Mimesis S.r.l., supported by the EMA’s guidance, is paving the way for future innovations in TB treatment and beyond. By addressing the specific feedback and expanding its data collection, Mimesis S.r.l. demonstrates its commitment to meeting the highest standards of regulatory compliance and medical efficacy.

Mimesis attended the “Giornata di Orientamento al lavoro e alle professioni”

We are thrilled to share the exciting news that our team was honored with an invitation to step inside the hallowed halls of the Faculty of Mathematics and Informatics at Unict. The purpose? To present Mimesis to a vibrant audience of young students and graduates eager to explore the frontiers of technology and innovation. 🤝 Building Bridges of Knowledge:The event was more than a presentation; it was a unique opportunity to connect with the bright minds that shape the future of our technological landscape. Interacting with the inquisitive students and graduates allowed us to not only showcase the capabilities of Mimesis but also to engage in meaningful discussions about the fascinating world of in Silico technology. 🌐 Educating Tomorrow’s Innovators:Being able to make young minds aware of our work and the advancements in in Silico technology is a triumph for us. The energy and enthusiasm in the room were palpable, reaffirming our belief in the power of knowledge sharing and education. 🙏 Gratitude and Acknowledgment:A heartfelt thank you to the Faculty of Mathematics and Informatics at Unict for extending the invitation, and a special appreciation to all who attended. Your curiosity and engagement fuel our passion for what we do. Join Us on the Journey:As we continue to push the boundaries of technology and innovation, we invite you to stay tuned for more updates on our journey. Together, let’s shape a future where knowledge knows no bounds. Education #InnovationJourney #MimesisPresentation #SilicoTechnology #FutureLeaders #WordPressBlog 🌟🔍

Mimesis at CMISF 2023

We are delighted to announce that our team member, Marzio Pennisi, recently graced the stage as a distinguished speaker at the 7th International Workshop on Computational Methods for the Immune System Function (CMISF 2023) in Istanbul on December 6th. 🎙️🔍 Exploring New Frontiers:Marzio’s presentation, titled “Modelling and Simulation of anakinra effects on severe Covid-19 patients,” delved into the intricate world of computational methods applied to the immune system. His insights showcased the potential of advanced simulations in understanding and mitigating severe Covid-19 cases. A Trailblazing Contribution:This significant achievement underscores our team’s unwavering commitment to cutting-edge research and innovation. Stay Tuned for More:As we continue to push the boundaries of research and innovation, stay tuned for more updates on our team’s endeavors. ResearchInnovation #CMISF2023 #Covid19Research #ComputationalMethods #TeamExcellence #WordpressBlog 🏆🚀 Take a look here for more info: https://bidma.cpsc.ucalgary.ca/IEEE-BIBM-2023/

Mimesis on “La Sicilia”

We are thrilled to share a momentous occasion for our team as the esteemed local newspaper, “La Sicilia”, featured our endeavors alongside other leading university start-ups at the recent ‘Borsa della Ricerca’ event. The event, held last month at the historic “Monastero dei Benedettini” in Catania, brought together innovation, research, and entrepreneurial spirit under one roof. Embracing Innovation:“La Sicilia” delved into the vibrant atmosphere of the ‘Borsa della Ricerca,’ capturing the essence of innovation that permeated the event. Our team’s presence alongside other university start-ups underscores the dynamic landscape of research and entrepreneurship flourishing in our community. Monastero dei Benedettini: A Historic Backdrop:The setting at the Monastero dei Benedettini added a touch of history and serenity to the event. Nestled in the heart of Catania, this historic location provided the perfect backdrop for showcasing the groundbreaking initiatives emerging from our local universities. A Grateful Journey:We extend our heartfelt gratitude to “La Sicilia” for recognizing and amplifying the impact of our work. Being featured among such esteemed company motivates us to continue pushing the boundaries of innovation and research. Join Us on the Journey:As we reflect on this milestone, we invite you to delve into the full article for a closer look at the exciting developments that unfolded at ‘Borsa della Ricerca.’ LaSicilia #BorsadellaRicerca #InnovationSpotlight #LocalEntrepreneurship #CataniaEvents #WordPressBlog 🗞️🌐

Avicenna Days: October 10/11/12 2023

We are elated to announce that our esteemed founder, Prof. Francesco Pappalardo, took center stage as a speaker at the prestigious 2023 Avicenna Days. This landmark event brought together luminaries in the field of research, and Prof. Pappalardo, alongside other leading figures, provided invaluable insights into the regulatory journey of in Silico medicine. 🌐 A Global Gathering of Minds: The 2023 Avicenna Days served as a nexus, seamlessly uniting regulators, scientists, researchers, and leaders from both industry and academia. This collaborative platform aimed to update the healthcare community on the latest breakthroughs and accomplishments in the adoption and deployment of in silico methods. 🎤 Prof. Pappalardo’s Illuminating Session: In a thought-provoking session, Prof. Francesco Pappalardo shared his expertise on the regulatory path of in Silico medicine. His insights, alongside those of other distinguished speakers, provided a comprehensive view of the advancements propelling this transformative field. 🌟 Shaping the Future of Healthcare: Being part of such a dynamic and forward-thinking forum reinforces our commitment to pushing the boundaries of innovation. The intersection of regulatory perspectives, scientific advancements, and collaborative efforts showcased at the Avicenna Days underscores the collective drive to shape the future of healthcare. 🙏 Gratitude and Inspiration: A heartfelt thank you to the organizers of the 2023 Avicenna Days for facilitating this enriching experience. We also express our gratitude to Prof. Pappalardo and the esteemed speakers who contributed to the wealth of knowledge shared during this event. Join Us on the Journey: As we continue our journey of innovation, stay tuned for more updates and insights into the ever-evolving landscape of in Silico medicine. #AvicennaDays #InSilicoMedicine #HealthcareInnovation #RegulatoryPath #ResearchLeadership #WordPressBlog 🌐🔍

Mimesis at EIT food 2023

On November 16th we were invited by Terza Missione Unict to join the event “Dall’idea alla start-up dalla ricerca al mercato” dedicated to researchers from different disciplines converging on the desire to make a positive impact on the planet and for people. It was a great experience, with many students interested in the world of start-ups attending. Thank you for inviting us and thank you to everyone who attended. More info here: https://www.unict.it/it/terza-missione/news/dallidea-alla-startup-dalla-ricerca-al-mercato-workshop-gratuito-ricercatori

eh 4 l

Mimesis is a new member of the Avicenna Alliance

It is an honour for us to have become part of this Alliance, which will certainly lead us to grow and learn a lot, both as a company and as people. Let us hope that this is the beginning of a long and worthwhile journey. Click on this link to find out more:https://avicenna-alliance.com/latest-news/news/mimesis-is-a-new-avicenna-member/